Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | -0.67% | -11.38% | -38.08% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Rallybio Corporation
Upcoming events on Rallybio Corporation
Past events on Rallybio Corporation
2024-05-15 09:00 am | Annual General Meeting |
2024-05-14 11:30 am | Citizens JMP Life Sciences Conference |
2024-05-09 08:00 am | Q1 2024 Earnings Release |
2024-04-17 02:00 pm | Academy of Managed Care Pharmacy Meeting - Poster Number: P1 |
2024-03-12 08:00 am | Q4 2023 Earnings Release |
2024-03-04 09:10 am | TD Cowen Health Care Conference - Panel |
2024-01-10 11:15 am | J.P. Morgan Health Care Conference |
2023-12-20 08:30 am | Business Update Call |
2023-12-09 08:30 pm | American Society of Hematology Meeting - Abstract No: 1224 |
2023-11-28 07:30 am | Evercore ISI HealthCONx Conference - Fireside Chat |
2023-11-15 03:00 pm | Stifel Healthcare Conference |
2023-11-09 08:00 am | Q3 2023 Earnings Release |
2023-10-10 11:00 am | JonesTrading Healthcare Summit |
2023-09-27 04:10 pm | Cantor Global Healthcare Conference |
2023-09-12 10:00 am | H.C. Wainwright Global Investment Conference |
2023-09-11 | H.C. Wainwright Global Investment Conference |
2023-09-07 12:45 pm | Wells Fargo Healthcare Conference |
2023-09-03 02:30 pm | International Complement Workshop Congress - Abstract Number: 36 |
2023-08-09 11:00 am | Wedbush PacGrow Healthcare Conference |
2023-08-08 08:00 am | Q2 2023 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -67,7 -70,2 3.59% | -78,8 -77,9 -1.19% | -57,3 |
EBIT Million USD | Released Forecast Spread | 0,00 | -45,6 -45,1 -1.21% | -67,9 -70,5 3.68% | -78,9 -77,8 -1.45% | -60,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -45,5 -45,1 -1% | -65,6 -66,7 1.68% | -72,5 -73,6 1.52% | -60,7 |
Net income Million USD | Released Forecast Spread | -26,4 | -47,0 -46,1 -2% | -66,7 -67,6 1.35% | -74,6 -73,9 -0.91% | -60,1 |
EPS USD | Released Forecast Spread | -9,95 | -1,84 -3,83 51.9% | -2,09 -2,38 12.16% | -1,84 -1,84 -0.02% | -1,71 |
Announcement Date | 22/07/21 | 15/03/22 | 06/03/23 | 12/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -17,1 -20,0 14.74% | -20,0 -19,0 -5.5% | -19,3 -21,0 7.97% | -21,1 -20,0 -5.38% | -19,0 | -15,0 | -12,0 | -10,0 | ||||||
EBIT Million USD | Released Forecast Spread | -14,3 -13,5 -6.45% | -17,6 -18,5 4.96% | -18,9 -16,4 -14.88% | -17,1 -19,8 13.62% | -18,4 -19,1 3.93% | -20,1 -19,8 -1.34% | -19,4 -21,7 10.91% | -21,1 -20,0 -5.82% | -19,8 -19,8 -0.14% | -15,1 | -12,8 | -12,6 | -11,7 | -12,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,1 -12,9 -9.36% | -17,2 -18,3 5.77% | -18,2 -16,0 -13.98% | -16,0 -19,3 16.94% | -16,8 -18,0 7.17% | -18,4 -18,9 2.35% | -17,7 -21,0 15.76% | -19,6 -19,3 -1.59% | -18,3 -18,6 1.38% | -15,3 | -13,7 | -14,3 | -11,2 | -11,6 |
Net income Million USD | Released Forecast Spread | -14,5 -13,8 -5.06% | -17,6 -18,4 4.57% | -18,4 -16,7 -10.16% | -16,2 -19,4 16.51% | -17,3 -18,5 6.34% | -18,6 -19,3 3.46% | -18,4 -20,8 11.83% | -20,2 -19,2 -5.24% | -19,0 -19,5 2.23% | -16,1 | -13,7 | -11,4 | -11,8 | -12,2 |
EPS USD | Released Forecast Spread | -0,48 -0,47 -2.13% | -0,57 -0,61 6.56% | -0,60 -0,54 -11.11% | -0,46 -0,60 22.85% | -0,43 -0,50 14.57% | -0,46 -0,48 3.92% | -0,45 -0,51 12.38% | -0,50 -0,45 -11.02% | -0,47 -0,47 0.84% | -0,41 | -0,37 | -0,38 | -0,33 | -0,33 |
Announcement Date | 10/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 09/05/23 | 08/08/23 | 09/11/23 | 12/03/24 | 09/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Rallybio Corporation
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RLYB Stock
- Calendar Rallybio Corporation